Scarica l'app Stockscreener
1.07
7.76%
-0.09
Dopo l'orario di chiusura:
1.08
0.01
+0.93%
Allakos Inc Borsa (ALLK) Ultime notizie
Allakos Inc. Alters Lease Agreement for Cost Savings - TipRanks
FMR LLC's Strategic Acquisition of Allakos Inc Shares - GuruFocus.com
Allakos's SWOT analysis: biotech firm's stock faces hurdles in CSU market - Investing.com
All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy - Yahoo Finance
FY2024 EPS Estimates for Allakos Raised by Leerink Partnrs - MarketBeat
Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Allakos perks up after early-stage data for lead asset - MSN
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat
3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St
Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St
Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR
The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World
Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR
Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR
Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily
Allakos Inc (ALLK)’s stock price range in the last year - US Post News
Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex
Allakos shares hold rating after trial update By Investing.com - Investing.com Australia
Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia
TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com
Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India
Allakos shares hold rating after trial update - Investing.com
Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha
Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com
Allakos reports positive results from AK006 Phase 1 study - Investing.com India
Allakos Progress Update on AK006 and Future Milestones - TipRanks
Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK
Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR
Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart
Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World
Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN
Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com
Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat
Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global
Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat
Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily
Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World
Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily
Allegion Stock: Is ALLE Outperforming The Industrials Sector? - Barchart
Alumis Inc. [ALMS] Stock bought by Insider Foresite Labs, LLC for $40.0 million - Knox Daily
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
Views of Wall Street’s Leading Experts on Alta Equipment Group Inc - SETE News
Trading Day Triumph: Allogene Therapeutics Inc (ALLO) Ends at 2.80, a -3.78 Surge/Plunge - The Dwinnex
Ally Bridge Group NY LLC Reduces Holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Alternus Clean Energy outlines plan to regain Nasdaq compliance - Proactive Investors Australia
Canada Pension Plan Investment Board Has $25.79 Million Position in Align Technology, Inc. (NASDAQ:ALGN) - Defense World
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):